Prognostic models for patients with metastatic urothelial carcinoma: why use them?

Affiliations

• ¹ Unit of Medical Oncology, University Hospital of Parma, Parma, Italy - michele.maffezzoli@unipr.it.
• ² Department of Urology, University Hospital of Parma, Parma, Italy.
• ³ Unit of Medical Oncology, San Paolo Hospital, Savona, Italy.
• ⁴ Department of Internal Medicine and Medical Specialties (Di.M.I.), University of Genoa, Genoa, Italy.
• ⁵ Department of Oncology, Portsmouth Hospitals University NHS Trust, Portsmouth, UK.
• ⁶ Unit of Medical Oncology, IRCCS San Martino University Hospital, Genoa, Italy.
• ⁷ Section of Biostatistics, Department of Health Sciences (DISSAL), University of Genoa, Genoa, Italy.
• ⁸ Center for Cancer, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.
• ⁹ Unit of Medical Oncology, University Hospital of Parma, Parma, Italy.
• ¹⁰ Department of Medicine and Surgery, University of Parma, Parma, Italy.